PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1383314
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1383314
According to Stratistics MRC, the Global Ambient Temperature Gel Permeation Chromatography Market is growing at a CAGR of 8.5% during the forecast period. Ambient Temperature Gel Permeation Chromatography (GPC) is an analytical technique used in chemistry and polymer science to separate and characterize macromolecules, particularly polymers, based on their molecular size. GPC is performed at ambient or room temperature. In GPC, a sample is dissolved in a suitable solvent and then passed through a column filled with a porous gel. Larger molecules cannot enter the pores and therefore elute more quickly, while smaller molecules enter the pores and elute later. This separation allows for the determination of molecular weight distribution and other size-related properties of polymers and macromolecules.
According to a report in 2017 by International Federation of Pharmaceutical Manufacturers and Associations, research based pharmaceutical and biotech companies annually invest around US$ 149 billion on research and development around world.
The increased use of ambient temperature gel permeation chromatography (GPC) in life sciences serves as a prominent driver for the market. GPC is invaluable in the biotechnology and pharmaceutical industries for characterizing biomolecules, including proteins, nucleic acids, and polysaccharides. It enables the precise determination of molecular weight distributions and the analysis of biomolecule size, essential for drug development, quality control, and regulatory compliance. As the life sciences sector experiences rapid growth and innovation, GPC's role in biomolecule analysis becomes increasingly significant. This, in turn, propels the demand for GPC instruments and services, making it a pivotal driver in the GPC market's expansion.
The high initial setup costs present a significant restraint in the ambient temperature gel permeation chromatography (GPC) market. Establishing a GPC laboratory requires a substantial investment in equipment, including chromatography systems, columns, detectors, and data analysis software. These expenses can deter smaller research institutions, laboratories, or startups with limited budgets from entering the market. Furthermore, ongoing maintenance, calibration, and consumables add to the financial burden.
The rising demand in biotechnology presents a significant opportunity for the ambient temperature gel permeation chromatography (GPC) market. GPC is a vital analytical tool for characterizing biomolecules, including proteins, nucleic acids, and carbohydrates, which are central to biotechnological research and pharmaceutical development. As the biotechnology industry continues to expand, with applications in drug discovery, biopharmaceuticals, and personalized medicine, there is a growing need for precise molecular weight determination and size analysis, making it an essential component in biotechnological research and product development.
Competition from alternative analytical techniques poses a significant threat to the ambient temperature gel permeation chromatography (GPC) market. While GPC is valuable for polymer characterization, newer, faster, and more versatile analytical methods, such as mass spectrometry and nuclear magnetic resonance spectroscopy, have gained prominence. These alternatives offer a broader range of applications, including structural elucidation and detailed molecular analysis. As a result, potential users may opt for these techniques over GPC, especially in high-throughput settings or when a deeper molecular understanding is required. Such aspects further hinder market expansion.
The COVID-19 pandemic has had a mixed impact on the ambient-temperature gel permeation chromatography market. While initial disruptions in supply chains and laboratory operations posed challenges, the market rebounded due to increased research activities related to the virus. GPC played a crucial role in characterizing biomolecules relevant to vaccine development and therapeutic research. However, reduced funding for non-COVID-19-related projects and limited access to laboratories during lockdowns temporarily slowed market growth. Overall, the pandemic underscored the importance of GPC in life sciences research but also highlighted the need for resilience and adaptability in the face of unforeseen disruptions.
The chemical and biochemical companies segment is expected to dominate the market during the forecast period. This projection is driven by the pivotal role of GPC in polymer analysis, biomolecule characterization, and material science, all of which are integral to the chemical and biochemical industries. Moreover, GPC serves as a fundamental tool for assessing molecular weight distribution and ensuring product quality in pharmaceuticals, biotechnology, and other sectors. With the continuous expansion of these industries and the growing need for precise analytical solutions, chemical and biochemical companies are poised to secure the largest market share.
The analytical systems segment is projected to experience substantial growth. This is due to the increasing demand for advanced analytical instrumentation. Analytical systems play a pivotal role in providing accurate and high-resolution data for polymer analysis, biomolecule characterization, and materials science. Furthermore, industries demand more precise and detailed insights into their materials and products, the need for cutting-edge GPC instruments, detectors, and data analysis software becomes crucial. With a focus on quality control, research, and regulatory compliance, the analytical systems is set to witness remarkable growth, driven by the rising demand for sophisticated GPC technology across various sectors.
North America is projected to dominate the Ambient Temperature Gel Permeation Chromatography market, primarily due to the region's well-established pharmaceutical, chemical, and biotechnology industries. The stringent quality control requirements and extensive research and development activities in these sectors drive the adoption of GPC for precise polymer analysis and biomolecule characterization. Additionally, a robust focus on regulatory compliance aligns with GPC's role in ensuring product quality and safety. Furthermore, the presence of key market players and advanced technological infrastructure further solidify North America's position emphasizing its pivotal role in the analytical sciences landscape.
The Asia Pacific region is poised to register lucrative growth in the ambient temperature gel permeation chromatography market. The region's expanding pharmaceutical, biotechnology, and chemical industries, along with increasing research and development activities, drive the demand for GPC in polymer analysis and biomolecule characterization. Additionally, as Asia Pacific economies continue to grow, there is a heightened emphasis on quality control and regulatory compliance. The presence of a burgeoning biopharmaceutical sector and a focus on technological advancements contribute to the region's attractiveness. As the need for precise analytical solutions rises, Asia Pacific is anticipated to experience growth, underscoring its significance in the market.
Some of the key players in Ambient Temperature Gel Permeation Chromatography Market include: Agilent Technologies, Gilson, Inc., J2 Scientific, LabAlliance, Labtech, Malvern Panalytical, Nittoseiko Analytech Co., Ltd, Polymer Char, PSS Polymer Standards Service, Schambeck SFD, Shimadzu Corporation, Tosoh Corporation, Waters Corporation and Wyatt Technology Corporation.
In September 2023, Laboratory Alliance opened its first Oneida County patient service center in September at 555 French Rd. in New Hartford, N.Y. Walk-in blood draw services are now available in four counties -Onondaga, Madison, Oswego and now Oneida.
In September 2023, Agilent Technologies Inc. recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre Singapore (NCCS) outlining their collaboration to accelerate translational cancer research on the genomic landscape of Asian-prevalent cancers over the next two years. The scope of the agreement includes the supply of an Agilent Magnis Next-Generation Sequencing (NGS) Preparation System to help investigate details specific to Asian cancer cohorts, where tissue samples derived from routine clinical care remain limited locally and regionally.